Vanderbilt infectious diseases specialist Anna Person, MD, has been named to a four-year term as vice-chair of the board of the HIV Medicine Association .

Vanderbilt University Medical Center scientists are launching a research platform called ELVIS that is devoted to molecular underpinnings of early-childhood determinants of health. The seven-year, $51 million project is being led by Infectious Diseases Dr. Suman Das. 

Vanderbilt researchers, including Clinical Pharmacology Dr. Elizabeth Rendina-Ruedy, have detailed how aging alters the metabolism of bone-forming cells, which could contribute to age-related osteoporosis.

The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has funded an ambitious initiative to overcome one of the most perplexing and frustrating mysteries of cancer treatment — how to prevent drug resistance. The three-year grant was awarded to Hematology and Oncology Dr. Ben Ho Park and Biochemistry Dr. Houra Merrikh. 

Following a successful pilot program, music therapy is now being offered to patients on three additional units at Vanderbilt University Hospital.

Upon receiving a $9.7 million grant from The Warren Alpert Foundation (WAF), the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) has partnered with Vanderbilt University School of Medicine (VUSM) and three other institutions to design and provide continuing education programs for genetic counselors. In the first year of funding, Kelly Taylor, MS, LCGC, CCRP, senior associate in Medicine (Genetic Medicine), will work with genetic counselors at the partnering institutions to develop online educational modules.

Drs. Sara Horst and Ashley Spann of the Department of Medicine's Division of Gastroenterology, Hepatology and Nutrition are among the 12 Vanderbilt faculty members currently serving two-year terms on 55 specialty steering boards, comprised of from 627 clinicians, constituted by Epic Systems Corp.

International workgroup issues additional guidance on how to manage patients who carry inherited CHEK2 gene mutations that put them at a higher risk for cancer.

Levels of the essential, branched-chain amino acids, valine, leucine and isoleucine, are involved in the regulation of lipid, glucose and protein metabolism.